BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24507797)

  • 1. Characterization of transcription factor AP-2 β mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency.
    Ji W; Benson MA; Bhattacharya S; Chen Y; Hu J; Li F
    J Surg Res; 2014 May; 188(2):466-472. PubMed ID: 24507797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.
    Chen YW; Zhao W; Zhang ZF; Fu Q; Shen J; Zhang Z; Ji W; Wang J; Li F
    Pediatr Cardiol; 2011 Oct; 32(7):958-65. PubMed ID: 21643846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tfap2b mutation in mice results in patent ductus arteriosus and renal malformation.
    Wang J; Ji W; Zhu D; Wang W; Chen Y; Zhang Z; Li F
    J Surg Res; 2018 Jul; 227():178-185. PubMed ID: 29804851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus.
    Khetyar M; Syrris P; Tinworth L; Abushaban L; Carter N
    Genet Test; 2008 Sep; 12(3):457-9. PubMed ID: 18752453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.
    Mani A; Radhakrishnan J; Farhi A; Carew KS; Warnes CA; Nelson-Williams C; Day RW; Pober B; State MW; Lifton RP
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2975-9. PubMed ID: 15684060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Char Syndrome a novel mutation and new insights: A clinical report.
    Massaad E; Tfayli H; Awwad J; Nabulsi M; Farra C
    Eur J Med Genet; 2019 Dec; 62(12):103607. PubMed ID: 30579973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning.
    Zhao F; Bosserhoff AK; Buettner R; Moser M
    PLoS One; 2011; 6(7):e22908. PubMed ID: 21829553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus.
    Satoda M; Zhao F; Diaz GA; Burn J; Goodship J; Davidson HR; Pierpont ME; Gelb BD
    Nat Genet; 2000 May; 25(1):42-6. PubMed ID: 10802654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense mutation in TFAP2B associated with Char syndrome and central diabetes insipidus.
    Edward HL; D'Gama AM; Wojcik MH; Brownstein CA; Kenna MA; Grant PE; Majzoub JA; Agrawal PB
    Am J Med Genet A; 2019 Jul; 179(7):1299-1303. PubMed ID: 31012281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFAP2B mutation and dental anomalies.
    Tanasubsinn N; Sittiwangkul R; Pongprot Y; Kawasaki K; Ohazama A; Sastraruji T; Kaewgahya M; Kantaputra PN
    J Hum Genet; 2017 Aug; 62(8):769-775. PubMed ID: 28381879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of TFAP2B in congenital heart disease patients in Mysore, South India.
    Lingaiah K; Sosalagere DM; Mysore SR; Krishnamurthy B; Narayanappa D; Nallur RB
    Indian J Med Res; 2011 Nov; 134(5):621-6. PubMed ID: 22199100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are not associated with the incidence of patent ductus arteriosus in Japanese preterm infants.
    Kawase K; Sugiura T; Nagaya Y; Yamada T; Sugimoto M; Ito K; Togawa T; Nagasaki R; Kato T; Kouwaki M; Koyama N; Saitoh S
    Pediatr Int; 2016 Jun; 58(6):461-6. PubMed ID: 26615960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of genetic research on Char syndrome].
    Zhao M; Fan L; Xiang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jun; 41(6):758-760. PubMed ID: 38818565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation.
    Zhao F; Weismann CG; Satoda M; Pierpont ME; Sweeney E; Thompson EM; Gelb BD
    Am J Hum Genet; 2001 Oct; 69(4):695-703. PubMed ID: 11505339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus.
    Vaughan CJ; Basson CT
    Am J Med Genet; 2000; 97(4):304-9. PubMed ID: 11376442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor AP-2beta in development, differentiation and tumorigenesis.
    Raap M; Gierendt L; Kreipe HH; Christgen M
    Int J Cancer; 2021 Sep; 149(6):1221-1227. PubMed ID: 33720400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Char syndrome, a familial form of patent ductus arteriosus, with a new finding: hypoplasia [corrected] of the 3rd finger.
    Babaoğlu K; Oruç M; Günlemez A; Gelb BD
    Anadolu Kardiyol Derg; 2012 Sep; 12(6):523-4. PubMed ID: 22728731
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of familial Char syndrome involving the TFAP2B gene with a focus on facial shape characteristics.
    Nyboe D; Kreiborg S; Darvann T; Dunø M; Nissen KR; Hove HB
    Clin Dysmorphol; 2018 Jul; 27(3):71-77. PubMed ID: 29683802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between PDA-associated polymorphisms and genetic ancestry alter ductus arteriosus gene expression.
    Clyman RI; Hills NK; Dagle JM; Murray JC; Kelsey K
    Pediatr Res; 2022 Mar; 91(4):903-911. PubMed ID: 33837257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the pathogenesis and genetic background of patency of the ductus arteriosus.
    Bökenkamp R; DeRuiter MC; van Munsteren C; Gittenberger-de Groot AC
    Neonatology; 2010 Jun; 98(1):6-17. PubMed ID: 19955832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.